Alcon reported a 10% year-on-year rise in quarterly revenue to $2.69 billion, driven by 10 new product launches, including next-generation cataract lenses. Operating earnings fell 32% to $292 million, ...

Q1 2026 earnings call insights: sales up 6%, guidance intact, tariff update, Unity & Tryptyr traction, and $1.5B buyback—read now.

In the U.S., Alcon gained approximately 2 share points in the PC-IOL category, driven by the PanOptix Pro trifocal lens and ...

Swiss-American eye care company Alcon ​reported a 10% rise ‌in its quarterly revenue, citing recent product launches as main drivers.

Alcon shares fell around 7% on Wednesday after the Swiss eye care company reported first-quarter sales that fell short of analyst expectations, even as it raised its full-year earnings outlook.

Alcon AG reports first-quarter earnings Tuesday after the close, testing whether the Swiss eye-care giant’s recent wave of product launches can sustain double-digit growth momentum even as analyst ...

Why Alcon (SWX:ALC) is on investors’ radar today Alcon (SWX:ALC) has drawn attention after recent trading left the stock with a year-to-date return of about an 8% decline and a one-year total return ...

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ...

Centurion Service Group, an industry-leading medical equipment lifecycle organization, in partnership with Auction Advisors, LLC, a premier auction and liquidation firm, today announced a major online ...

FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of Clareon ® TruPlus, its new enhanced design ...